Found 0 matching trials
Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer PHASE1 The purpose of this research study is to learn if your own immune cells can...
Show More Location
Duke University Medical Center
Learn More & Join Trial
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer PHASE1 This is a study to investigate the efficacy and safety of an infusion of IO...
Show More Location
The Angeles Clinic and Research Institute
Learn More & Join Trial
TAA6 Cell Injection In The Treatment of Patients With Relapsed / Refractory Acute Myeloid Leukemia NA This is a clinical study of TAA6 cell injection in the treatment of patient...
Show More Location
Anhui Provincial Hospital
Learn More & Join Trial
A New EBV Related Technologies of T Cells in Treating Malignant Tumors and Clinical Application PHASE1 The purpose of this study is to evaluate the safety of the designed LMP1-CA...
Show More Learn More & Join Trial
Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT PHASE2 To evaluate if hyper-fractionated TBI or TMLI followed by Treg/Tcon adoptiv...
Show More Location
University of Perugia
Learn More & Join Trial
To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT PHASE1 To observe the efficacy and safety of CD7-targeted chimeric antigen recepto...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Biological Therapy in Treating Patients With Metastatic Melanoma PHASE1 RATIONALE: Biological therapies such as cellular adoptive immunotherapy use...
Show More Location
Fred Hutchinson Cancer Research Center
Learn More & Join Trial
Lymphocyte Re-infusion During Immune Suppression to Treat Metastatic Melanoma PHASE2 This experiment will test the safety and effectiveness of a treatment for m...
Show More Location
National Cancer Institute (NCI)
Learn More & Join Trial
NG2 and DLL3 CAR-T Cells Targeting Melanoma PHASE1 The purpose of this study is to assess the feasibility, safety and efficacy...
Show More Location
Shenzhen Geno-immune Medical Institute
Learn More & Join Trial
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma PHASE2 Background:
* The National Cancer Institute (NCI) Surgery Branch has devel...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial